Not Yet Recruiting
A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer
NCT07485920
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited-stage Small Cell Lung Cancer (LS-SCLC), +8 more
- Locations
-
- Affiliated Hospital of Qingdao University Qingdao, Shandong, China
- Qingdao Central Hospital Affiliated to Rehabilitation University Qingdao, Shandong, China
- Qingdao Municipal Hospital Qingdao, Shandong, China
- Weihai Municipal Hospital Weihai, Shandong, China